Nicotinamide in the Treatment of Psoriasis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Psoriasis
Interventions
DRUG

Calcipotriol plus Nicotinamide

Patients applied calcipotriol 0.005% and nicotinamide 4% in combination (By LEO Pharmaceuticals, Ballerup, Denmark) for lesions of one side of the body. The patients uses the medications twice daily (in the morning and before sleeping) for 12 weeks; the total doses of medication used not more than 100 gram per week.

DRUG

Calcipotriol

Patients applied calcipotriol 0.005% (By LEO Pharmaceuticals, Ballerup, Denmark) for lesions of the other side of the body. The patients uses the medications twice daily (in the morning and before sleeping) for 12 weeks; the total doses of medication used not more than 100 gram per week.

Trial Locations (1)

Unknown

Skin Diseases and Leishmaniasis Research Center, Isfahan

All Listed Sponsors
lead

Isfahan University of Medical Sciences

OTHER

NCT01763424 - Nicotinamide in the Treatment of Psoriasis | Biotech Hunter | Biotech Hunter